by John Conrad | Oct 24, 2023 | iBIO News, Policy News
Key Points • iBIO is advocating for HR1651, the Ensuring Patient Access to Critical Breakthrough Products Act, to provide seniors with quicker access to life-saving medical technologies. • This bipartisan legislation seeks to create a 4-year automatic coverage period...
by John Conrad | Oct 9, 2023 | iBIO News
10/6/2023 Op-Ed John Conrad, president and CEO, Illinois Biotechnology Innovation Organization Companies often talk about making a difference, but few are willing to commit the time, talent and treasure needed to create change. On behalf of the Illinois life sciences...
by John Conrad | Oct 2, 2023 | iBIO News, Policy News
Representatives John Joyce, M.D. (R-PA) and Wiley Nickel (D-NC) have recently introduced the Optimizing Research Progress Hope And New Cures (ORPHAN Cures Act). This legislation is a significant step in addressing the negative impact of the Inflation Reduction Act...
by John Conrad | Aug 30, 2023 | iBIO News, Policy News
iBIO has consistently advocated for a fast and efficient approach to Medicare coverage for groundbreaking medical devices and diagnostics that enhance patient outcomes in cases of severe or life-threatening illnesses. We commend CMS for revisiting this vital matter....
by John Conrad | Jul 11, 2023 | iBIO News
A recent workforce trends report supported by iBIO highlights the impressive growth of the biosciences industry in Illinois. This report is based on data collected from member surveys and interviews about current and future hiring needs and analyzing Illinois job...
by John Conrad | Jun 26, 2023 | iBIO News
Last week, 118 young girls from the third to eighth-grade range had the unique opportunity to immerse themselves in science, technology, engineering, and mathematics (STEM) at the 2023 iBIO STEMgirls Summer Camp. This year’s camp focused on engineering to limit...